Methods for intravesical administration of a therapeutic agent including application of a photoactive nanogel to the mucosal surfaces of the bladder and/or intravesical application of cell-penetrating peptides. Photoactive nanogels may be aggregated by exposure to ultraviolet light, either in vitro or in vivo, to provide controlled or extended release of a therapeutic agent, such as an antibiotic.

Methods for intravesical administration of a therapeutic agent including application of a photoactive nanogel to the mucosal surfaces of the bladder and/or intravesical application of cell-penetrating peptides. Photoactive nanogels may be aggregated by exposure to ultraviolet light, either in vitro or in vivo, to provide controlled or extended release of a therapeutic agent, such as an antibiotic.

An antibiotic bead having a size of from about 0.5 to about 20 millimeter is provided. The bead comprises an antibiotic agent dispersed within a polymer matrix, the polymer matrix containing a semi-crystalline olefin copolymer.

An antibiotic bead having a size of from about 0.5 to about 20 millimeter is provided. The bead comprises an antibiotic agent dispersed within a polymer matrix, the polymer matrix containing a semi-crystalline olefin copolymer.

The present disclosure discloses a medical material and a product and preparation method thereof. The medical material comprises a ferroelectric polymer, and optionally further comprises an inorganic ferroelectric particle. The composite membrane is prepared by experiencing at least one of annealing treatment, corona poling treatment, acid treatment, and ultrasonic treatment, and the acid treatment is conducted after the annealing treatment. The present disclosure further relates to a method for treating a composite membrane to regulate an antibacterial activity.

Provided herein are materials for the promotion of tissue regeneration, and methods of promoting tissue regeneration and wound healing therewith. In particular, materials displaying laminin-derived peptide sequences that facilitate cell migration into the material, and methods of use thereof, are provided.

Described are pressure-sensitive adhesive polymers (PSAs) useful, for example, for application to the skin, such as in the field of transdermal drug delivery. The PSAs include polar groups modeled on one or more polar portions of skin lipids, which contribute to good skin adhesion properties. Methods of making the PSAs, compositions comprising them, and methods of making and using them also are provided.

The subject of the present invention is a composite wound packing material comprising a casing enclosing a material, or an assembly of materials, forming fluid flow channels, said casing being composed of a self-supporting interface material formed from a thin layer of a composition comprising a hydrophobic matrix and comprising through-holes, said hydrophobic matrix comprising, per 100 parts by weight of a styrene/saturated olefin/styrene triblock copolymer having a viscosity of between 0.2 and 2 Pa.Math.s, as measured in a 10% (weight/weight) solution in toluene, from 400 to 1220 parts by weight of a plasticizer, preferably a plasticizing oil, and from 0 to 720 parts by weight of petroleum jelly, it being specified, moreover, that the total amount of plasticizer and petroleum jelly is greater than or equal to 750 parts by weight and the amount of petroleum jelly is between 400 and 720 parts by weight when the amount of plasticizer is between 1000 and 1220 parts by weight.

Described are polymers and methods of forming and using same.

Described are polymers and methods of forming and using same.